7

result(s)

Word(s)
Publication type
Policy area
Keyword
Date

Public health

01-02-2018

The Treaty of Lisbon has enhanced the importance of health policy, stipulating that ‘a high level of human health protection shall be ensured in the definition and implementation of all Community policies and activities’. This objective is to be achieved through Community support to Member States and by fostering cooperation. Primary responsibility for health protection and, in particular, the healthcare systems continues to lie with the Member States. However, the EU has an important role to play ...

The Treaty of Lisbon has enhanced the importance of health policy, stipulating that ‘a high level of human health protection shall be ensured in the definition and implementation of all Community policies and activities’. This objective is to be achieved through Community support to Member States and by fostering cooperation. Primary responsibility for health protection and, in particular, the healthcare systems continues to lie with the Member States. However, the EU has an important role to play in improving public health, preventing and managing diseases, mitigating sources of danger to human health, and harmonising health strategies between Member States. The EU has successfully implemented a comprehensive policy, through the Health Strategy ‘Health for Growth’ and its action programme (2014-2020) and a body of secondary legislation. The current institutional set-up to support implementation includes the Commission’s Directorate-General for Health and Food Safety (DG SANTE), as well as specialised agencies, notably the European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA).

Medicines and Medical Devices

01-02-2018

Medicines and medical devices are products subject to the rules of the single market, and therefore the EU holds competency for their authorisation through evaluation and supervision. In order to protect public health, before being placed on the market new pharmaceuticals for human use must be authorised under a centralised procedure by the European Medicines Agency (EMA) and/or in a decentralised manner by national agencies. Medical devices require a detailed regulatory framework for market access ...

Medicines and medical devices are products subject to the rules of the single market, and therefore the EU holds competency for their authorisation through evaluation and supervision. In order to protect public health, before being placed on the market new pharmaceuticals for human use must be authorised under a centralised procedure by the European Medicines Agency (EMA) and/or in a decentralised manner by national agencies. Medical devices require a detailed regulatory framework for market access through private-sector organisations called notified bodies; revisions are ongoing and a new legislative approach will come into force in 2017.

Commitments Made at the Hearings of the Commissioners-Designate, Juncker Commission (November 2014 - October 2019)

14-11-2014

This compilation of briefings presents the most salient points and essential commitments made by the commissioners-designate during the hearings held in September/October 2014 before the parliamentary committees. These commitments concern the main on-going legislative procedures, the preparation of future legislative proposals as well as the scrutiny of the implementation of existing legislation. They also touch upon the crucial issue of inter-institutional cooperation.

This compilation of briefings presents the most salient points and essential commitments made by the commissioners-designate during the hearings held in September/October 2014 before the parliamentary committees. These commitments concern the main on-going legislative procedures, the preparation of future legislative proposals as well as the scrutiny of the implementation of existing legislation. They also touch upon the crucial issue of inter-institutional cooperation.

Commitments Made at the Hearing of Vytenis Andriukaitis - Commissioner-Designate

04-11-2014

Briefing summarises commitments made at the hearing of Vytenis Andriukaitis Commissioner designate for Health & Food Safety.

Briefing summarises commitments made at the hearing of Vytenis Andriukaitis Commissioner designate for Health & Food Safety.

Commitments Made at the Hearing of Miguel Arias Cañete - Commissioner-Designate

04-11-2014

Briefing summarises commitments made at the hearing Miguel Arias Cañete Commissioner designate for Climate Action & Energy.

Briefing summarises commitments made at the hearing Miguel Arias Cañete Commissioner designate for Climate Action & Energy.

Disease Mongering (Pseudo-Disease Promotion)

15-11-2012

Disease mongering is the promotion of pseudo-diseases by the pharmaceutical industry aiming at economic benefit. Medical equipment manufacturers, insurance companies, doctors or patient groups may also use it for monetary gain or influence. It has increased in parallel with society's 'medicalisation' and the growth of the pharmaceutical complex. Due to massive investments in marketing and lobbying, ample use of internet and media, and the emergence of new markets, it is becoming a matter of concern ...

Disease mongering is the promotion of pseudo-diseases by the pharmaceutical industry aiming at economic benefit. Medical equipment manufacturers, insurance companies, doctors or patient groups may also use it for monetary gain or influence. It has increased in parallel with society's 'medicalisation' and the growth of the pharmaceutical complex. Due to massive investments in marketing and lobbying, ample use of internet and media, and the emergence of new markets, it is becoming a matter of concern, and policy makers should be aware of its perils and consequences.

Workshop Report on 'Health in All Policies (HiAP)' - Brussels, 25 May 2011

15-08-2011

For many years the health consequences of new legislation have been taken into account during the policy formulation process in areas such as agriculture, environment, food and others. The inclusion of Health in All Policies is now enshrined in the Lisbon Treaty (Art. 168). The aim of the workshop was to present an update on how the system is actually functioning within the different Commission services. Several DGs representatives, led by DG SANCO, made contributions. The case of The Netherlands ...

For many years the health consequences of new legislation have been taken into account during the policy formulation process in areas such as agriculture, environment, food and others. The inclusion of Health in All Policies is now enshrined in the Lisbon Treaty (Art. 168). The aim of the workshop was to present an update on how the system is actually functioning within the different Commission services. Several DGs representatives, led by DG SANCO, made contributions. The case of The Netherlands as an example of how it works in a Member State was also presented.

Upcoming events

01-10-2019
Health threats from climate change: Scientific evidence for policy-making
Other event -
EPRS

Partners

Stay connected

email update imageEmail updates system

You can follow anyone or anything linked to the Parliament using the email updates system, which sends updates directly to your mailbox. This includes the latest news about MEPs, committees, the news services or the Think Tank.

You can access the system from any page on the Parliament website. To sign up and receive notifications on Think Tank, simply submit your email address, select the subject you are interested in, indicate how often you want to be informed (daily, weekly or monthly) and confirm the registration by clicking on the link that will be emailed to you.

RSS imageRSS feeds

Follow all news and updates from the European Parliament website by making use of our RSS feed.

Please click on the link below to configure your RSS feed.